Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Internal Consistency of Measurement and Potential of a DNA-adduct as a Biomarker of Glycemic Control

NCT02065310 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT02065310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02065310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Internal Consistency of Measurement and Potential of a DNA-adduct as a Biomarker of Glycemic Control
Lead sponsor
City of Hope Medical Center
Phase
Not applicable
Overall status
Completed
Start date
October 30, 2014
Completion date
February 11, 2019
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes